NCT00348764View on ClinicalTrials.gov

ESGVS: Sclerotherapy With Lauromacrogol

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

December 31, 2006

Conditions
Venous InsufficiencySaphenous Vein
Interventions
DRUG

lauromacrogol

Trial Locations (1)

38000

Center of Vascular Medecine - 7 rue Lesdiguières, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT00348764 - ESGVS: Sclerotherapy With Lauromacrogol | Biotech Hunter | Biotech Hunter